Trump demands drug price cuts, retail traders stay bullish
Trump gave 18 pharma giants 60 days to match US drug prices with global lows or face federal action. Letters outlined MFN pricing, direct-to-patient sales, and price parity for Medicaid. Despite the pressure, retail sentiment turned bullish for stocks like ABBV, LLY, BMY, and NVO, with high message volume on Stocktwits.